The largest community of pharma leaders

Admin

1932 articles

VelosBio Announces First Patient Dosed in Phase 2 Trial of VLS-101 in Solid Tumors

SAN DIEGO--(BUSINESS WIRE)--VelosBio Inc. (VelosBio), a clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1), today...

CAP Calls on Medicare to Cease Implementation of Payment Cuts for COVID-19 Tests

WASHINGTON--(BUSINESS WIRE)--The College of American Pathologists (CAP) strongly objected to Medicare cuts to fees for certain COVID-19 tests, which the Centers for Medicare &...

Dr. Reddy’s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, today announced...